Heron Therapeutics Inc (NASDAQ:HRTX), a biotechnology company focused on improving the lives of patients by developing best-in-class medicines that address major unmet medical needs, …
Recently, various executives have taken part in insider trading activity for the stocks of Cisco Systems, Inc.(NASDAQ:CSCO), Heron Therapeutics Inc (NASDAQ:HRTX), and FireEye Inc (NASDAQ:FEYE).
In a research report released today, Cowen analyst Boris Peaker maintained an Outperform rating on shares of Heron Therapeutics Inc (NASDAQ:HRTX), and raised the …
In a research report released Monday, Brean Capital analyst Jonathan Aschoff maintained a Buy rating on Heron Therapeutics Inc (NASDAQ:HRTX) and raised the …
Heron Therapeutics Inc (NASDAQ:HRTX), a biotechnology company focused on improving the lives of patients by developing best-in-class medicines that address major unmet medical …
Cowen & Co. analyst Boris Peaker initiated coverage on shares of Heron Therapeutics Inc (NASDAQ:HRTX) with an Outperform rating and a price target of …
Leerink Swann analyst Jason Gerberry came out with some commentary on Heron Therapeutics Inc (NASDAQ:HRTX) following the initiation of a Phase 2 clinical trial of …
Heron Therapeutics Inc (NASDAQ:HRTX) announced that it has initiated a Phase 2 clinical trial of HTX-011, the Company’s lead product candidate for the …
Heron Therapeutics Inc (NASDAQ:HRTX), announced closing of its underwritten public offering of 5,520,000 shares of common stock, including 720,000 shares sold pursuant to …
